Feb 08, 2016 13:03 pm UTC| Business
CORAL GABLES, Fla., Feb. 08, 2016 -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases,...
EVINE Live Inc. Announces Preliminary Fiscal 2015 Fourth Quarter Results
Feb 08, 2016 13:01 pm UTC| Business
MINNEAPOLIS, Feb. 08, 2016 -- EVINE Live Inc. (NASDAQ:EVLV) today announced preliminary unaudited results for the fourth quarter of fiscal 2015: Net sales expected to be between $209 and $212 millionGross profit as a...
Feb 08, 2016 13:00 pm UTC| Business
TEL-AVIV, Israel, Feb. 08, 2016 -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), an Israeli biopharmaceutical company primarily focused on the development and commercialization of late...
OncoMed Provides Update on Tarextumab Phase 2 Programs
Feb 08, 2016 13:00 pm UTC| Business
REDWOOD CITY, Calif., Feb. 08, 2016 -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), a clinical-stage company developing novel anti-cancer stem cell and immuno-oncology therapeutics, announced updates on the tarextumab...
Feb 08, 2016 13:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 08, 2016 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company focused on developing meaningful therapies for patients with severe and life-threatening diseases that...
EVINE Live Inc. Announces Changes in Senior Management
Feb 08, 2016 13:00 pm UTC| Business
MINNEAPOLIS, Feb. 08, 2016 -- EVINE Live Inc. (NASDAQ:EVLV) today announced that its Board of Directors has appointed Bob Rosenblatt, Chairman of the EVINE Live Board, as interim Chief Executive Officer, effective...
Feb 08, 2016 13:00 pm UTC| Business
DEERFIELD, Ill., Feb. 08, 2016 -- Surgical Care Affiliates, Inc. (NASDAQ:SCAI) (“SCA”) today announced that it will release its fourth quarter and full year 2015 financial results prior to U.S. financial markets opening...